Ajanta Pharma [AJANTPHARM] vs Dr. Reddy's [DRREDDY] Detailed Stock Comparison

Ajanta Pharma

NSE
Loading...

Dr. Reddy's

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Ajanta Pharma wins in 10 metrics, Dr. Reddy's wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricAjanta PharmaDr. Reddy'sBetter
P/E Ratio (TTM)32.2418.59Dr. Reddy's
Price-to-Book Ratio7.962.97Dr. Reddy's
Debt-to-Equity Ratio1.3413.75Ajanta Pharma
PEG Ratio7.009.65Ajanta Pharma
EV/EBITDA22.8811.43Dr. Reddy's
Profit Margin (TTM)19.35%16.99%Ajanta Pharma
Operating Margin (TTM)25.73%20.50%Ajanta Pharma
EBITDA Margin (TTM)25.73%20.50%Ajanta Pharma
Return on Equity24.28%17.71%Ajanta Pharma
Return on Assets (TTM)18.35%9.71%Ajanta Pharma
Free Cash Flow (TTM)$8.39B$12.03BDr. Reddy's
Dividend Yield1.08%11.59%Dr. Reddy's
1-Year Return-27.76%-5.92%Dr. Reddy's
Price-to-Sales Ratio (TTM)6.243.15Dr. Reddy's
Enterprise Value$295.77B$1,021.70BDr. Reddy's
EV/Revenue Ratio6.153.06Dr. Reddy's
Gross Profit Margin (TTM)78.82%56.91%Ajanta Pharma
Revenue per Share (TTM)$385$401Dr. Reddy's
Earnings per Share (Diluted)$74.45$67.16Ajanta Pharma
Beta (Stock Volatility)0.180.33Ajanta Pharma
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Ajanta Pharma vs Dr. Reddy's Stock Performance Analysis

Loading Price Chart...

Ajanta Pharma
Dr. Reddy's
Ajanta Pharma Stock Overview | Dr. Reddy's Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ajanta Pharma0.15%-2.57%-6.09%-8.73%-8.37%-19.79%
Dr. Reddy's0.27%-0.40%-1.12%-3.35%8.39%-8.83%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ajanta Pharma-27.76%90.57%52.58%60.99%7,457.58%21,249.33%
Dr. Reddy's-5.92%42.59%21.10%46.56%299.93%1,228.33%

News Based Sentiment: Ajanta Pharma vs Dr. Reddy's

Ajanta Pharma

News based Sentiment: MIXED

September presented a mixed bag for Ajanta Pharma, with positive financial results and 'Buy' ratings countered by a declining stock price and a 'Negative Bias' listing. This complexity warrants a closer look, making it a significant month for investors tracking the company's performance.

View Ajanta Pharma News Sentiment Analysis

Dr. Reddy's

News based Sentiment: MIXED

Dr. Reddy's reported positive revenue growth in Q1 FY25, but operating profit decreased slightly. Analyst sentiment remains positive with a range of price targets, and the company is maintaining regulatory compliance. The upcoming Q2 FY26 results will be key to understanding the company's trajectory.

View Dr. Reddy's News Sentiment Analysis

Performance & Financial Health Analysis: Ajanta Pharma vs Dr. Reddy's

MetricAJANTPHARMDRREDDY
Market Information
Market Cap i₹302.49B₹1.05T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i106,4511,976,813
90 Day Avg. Volume i103,9221,551,516
Last Close₹2,401.80₹1,248.10
52 Week Range₹2,327.30 - ₹3,428.00₹1,020.00 - ₹1,405.90
% from 52W High-29.94%-11.22%
All-Time High₹3,485.00 (Sep 09, 2024)₹1,421.49 (Aug 19, 2024)
% from All-Time High-31.08%-12.20%
Growth Metrics
Quarterly Revenue Growth0.14%0.11%
Quarterly Earnings Growth0.04%0.02%
Financial Health
Profit Margin (TTM) i0.19%0.17%
Operating Margin (TTM) i0.26%0.21%
Return on Equity (TTM) i0.24%0.18%
Debt to Equity (MRQ) i1.3413.75
Cash & Liquidity
Book Value per Share (MRQ)₹301.59₹420.56
Cash per Share (MRQ)₹48.84₹80.12
Operating Cash Flow (TTM) i₹12.01B₹52.56B
Levered Free Cash Flow (TTM) i₹9.20B₹14.23B
Dividends
Last 12-Month Dividend Yield i1.08%11.59%
Last 12-Month Dividend i₹28.00₹146.30

Valuation & Enterprise Metrics Analysis: Ajanta Pharma vs Dr. Reddy's

MetricAJANTPHARMDRREDDY
Price Ratios
P/E Ratio (TTM) i32.2418.59
Forward P/E i24.173.64
PEG Ratio i7.009.65
Price to Sales (TTM) i6.243.15
Price to Book (MRQ) i7.962.97
Market Capitalization
Market Capitalization i₹302.49B₹1.05T
Enterprise Value i₹295.77B₹1.02T
Enterprise Value Metrics
Enterprise to Revenue i6.153.06
Enterprise to EBITDA i22.8811.43
Risk & Other Metrics
Beta i0.180.33
Book Value per Share (MRQ) i₹301.59₹420.56

Financial Statements Comparison: Ajanta Pharma vs Dr. Reddy's

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AJANTPHARMDRREDDY
Revenue/Sales i₹13.03B₹85.45B
Cost of Goods Sold i₹2.76B₹36.83B
Gross Profit i₹10.27B₹48.63B
Research & Development iN/A₹6.24B
Operating Income (EBIT) i₹6.83B₹16.84B
EBITDA i₹3.78B₹23.41B
Pre-Tax Income i₹3.31B₹19.05B
Income Tax i₹757.90M₹4.95B
Net Income (Profit) i₹2.55B₹14.10B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AJANTPHARMDRREDDY
Cash & Equivalents i₹1.75B₹14.65B
Total Current Assets i₹28.43B₹250.11B
Total Current Liabilities i₹9.96B₹130.39B
Long-Term Debt i₹347.20M₹7.86B
Total Shareholders Equity i₹37.90B₹337.17B
Retained Earnings i₹36.72B₹315.79B
Property, Plant & Equipment i₹17.16B₹0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AJANTPHARMDRREDDY
Operating Cash Flow iN/A₹27.79B
Capital Expenditures iN/A₹-7.67B
Free Cash Flow iN/A₹10.75B
Debt Repayment iN/A₹-253.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAJANTPHARMDRREDDY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i106,4511,976,813
Average Daily Volume (90 Day) i103,9221,551,516
Shares Outstanding i124.91M832.00M
Float Shares i42.11M591.38M
% Held by Insiders i0.66%0.29%
% Held by Institutions i0.20%0.52%

Dividend Analysis & Yield Comparison: Ajanta Pharma vs Dr. Reddy's

MetricAJANTPHARMDRREDDY
Last 12-Month Dividend i₹28.00₹146.30
Last 12-Month Dividend Yield i1.08%11.59%
3-Year Avg Annual Dividend i₹25.33₹49.30
3-Year Avg Dividend Yield i0.90%3.74%
3-Year Total Dividends i₹76.00₹147.90
Ex-Dividend DateNov 06, 2024Jul 10, 2025